Apoptosis induction by glucuronoxylomannan of Cryptococcus neoformans

被引:31
作者
Chiapello, LS [1 ]
Aoki, MP [1 ]
Rubinstein, HR [1 ]
Masih, DT [1 ]
机构
[1] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim & Clin, RA-5000 Cordoba, Argentina
关键词
apoptosis; Cryptococcus neoformans; glucuronoxylomannan; immunosuppression;
D O I
10.1080/1369378031000137260
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We Studied the ability of glucuronoxylomannan (GXM), the major constituent of Cryptococcus neoformans capsular polysaccharide, to induce apoptosis in lymphocytes from normal rats. Spleen mononuclear cells (Smc) from normal rats treated with GXM for 24 h exhibited, in comparison with controls, an increased hypodiploidy in the DNA profile after staining with propidium iodide, as well as increased ladder-type DNA fragmentation in agarose gel electrophoresis and a high number of positive cells in the terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL) reaction. Furthermore, increased hypodiploidy in the DNA profile was also observed in Smc expressing T-cell receptor (TCR+). We also studied the induction of apoptosis in lungs and spleens from rats in the immunosuppressor period of disseminated cryptococcosis. TUNEL labeling of lungs and spleens from rats obtained 14 days after infection with C. neoformans showed a large number of apoptotic cells. Our results provide strong cytometric, molecular and morphological evidence that apoptosis could be a previously unrecognized immunosuppressive property of GXM in vitro. This programmed cell death may be involved in the immunosuppression observed during C. neoformans infection.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 40 条
[1]  
ALBINA JE, 1993, J IMMUNOL, V150, P5080
[2]   Lung infections - Role of apoptosis in host defense and pathogenesis of disease [J].
Behnia, M ;
Robertson, KA ;
Martin, WJ .
CHEST, 2000, 117 (06) :1771-1777
[3]   FACILITATED ISOLATION, PURIFICATION, AND ANALYSIS OF GLUCURONOXYLOMANNAN OF CRYPTOCOCCUS-NEOFORMANS [J].
CHERNIAK, R ;
MORRIS, LC ;
ANDERSON, BC ;
MEYER, SA .
INFECTION AND IMMUNITY, 1991, 59 (01) :59-64
[4]   POLYSACCHARIDE ANTIGENS OF THE CAPSULE OF CRYPTOCOCCUS-NEOFORMANS [J].
CHERNIAK, R ;
SUNDSTROM, JB .
INFECTION AND IMMUNITY, 1994, 62 (05) :1507-1512
[5]   Mechanisms for induction of immunosuppression during experimental cryptococcosis: Role of glucuronoxylomannan [J].
Chiapello, L ;
Iribarren, P ;
Cervi, L ;
Rubinstein, H ;
Masih, DT .
CLINICAL IMMUNOLOGY, 2001, 100 (01) :96-106
[6]   INFECTIONS WITH CRYPTOCOCCUS-NEOFORMANS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
CHUCK, SL ;
SANDE, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (12) :794-799
[7]   INTRAVASCULAR CRYPTOCOCCAL CULTURE FILTRATE (CNEF) AND ITS MAJOR COMPONENT, GLUCURONOXYLOMANNAN, ARE POTENT INHIBITORS OF LEUKOCYTE ACCUMULATION [J].
DONG, ZM ;
MURPHY, JW .
INFECTION AND IMMUNITY, 1995, 63 (03) :770-778
[8]   COLORIMETRIC METHOD FOR DETERMINATION OF SUGARS AND RELATED SUBSTANCES [J].
DUBOIS, M ;
GILLES, KA ;
HAMILTON, JK ;
REBERS, PA ;
SMITH, F .
ANALYTICAL CHEMISTRY, 1956, 28 (03) :350-356
[9]  
FEHSEL K, 1995, J IMMUNOL, V155, P2858
[10]   Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection [J].
Feldmesser, M ;
Kress, Y ;
Novikoff, P ;
Casadevall, A .
INFECTION AND IMMUNITY, 2000, 68 (07) :4225-4237